InferTrust™ Is Now Patent Pending: Why It Matters for AI Decision Integrity

illuminis announces that InferTrust™, the AI decision integrity platform, has achieved patent-pending status. Here is what this milestone means for organization

A Milestone for AI Decision Integrity

Today, illuminis is pleased to announce that InferTrust™ has achieved patent-pending status. After months of development, architecture refinement, and rigorous documentation, we have successfully filed our patent application covering the core innovations that make InferTrust™ unique in the AI governance landscape.

This is a significant milestone, not just for illuminis, but for every organization that needs verifiable proof of how their AI systems make decisions.

Why Patent Protection Matters for AI Governance

The market for AI governance and compliance tools is growing rapidly. As regulations accelerate across healthcare, financial services, automotive, and manufacturing, organizations are evaluating platforms that claim to provide AI accountability. But not all approaches are equal.

Many solutions in this space rely on conventional logging, observability dashboards, and metadata capture. These are useful tools, but they share a fundamental limitation: they produce records that can be modified after the fact. When the stakes involve regulatory enforcement, litigation, or patient safety, mutable records are not sufficient.

InferTrust™ takes a fundamentally different approach. The patent application covers innovations that provide cryptographic certainty about AI decisions at the moment they are made, before any downstream system can alter the record. This distinction is what separates decision integrity from decision logging.

What This Means for Our Customers and Partners

For organizations evaluating InferTrust™, the patent-pending status provides several important assurances:

The Regulatory Tailwind

The timing of this milestone aligns with an accelerating regulatory environment. The FDA is increasing oversight of AI/ML-based medical devices. CMS is proposing rules for AI transparency in coverage determinations. Financial regulators are tightening expectations around AI model governance under SR 11-7. NHTSA is developing frameworks for autonomous vehicle AI accountability. The EU AI Act is creating compliance requirements that will affect global organizations.

In every one of these domains, organizations will need to produce verifiable evidence of how AI systems make decisions. The question is not whether AI governance will be required, but how soon. Organizations that invest in decision integrity infrastructure now will be positioned to meet these requirements when enforcement begins, rather than scrambling to retrofit after the fact.

What Comes Next

The patent filing is a milestone, not a finish line. We continue to invest in expanding InferTrust™'s capabilities across industries, deepening integration options for technology partners, and building the partner ecosystem that will bring AI decision integrity to organizations worldwide.

If you are evaluating AI governance solutions for your organization, or if you are a technology vendor interested in embedding decision integrity into your platform, we invite you to contact our team to discuss how InferTrust™ can support your requirements.